Role of substrates in diabetes therapy: Stem cell differentiation and islet transplantation

Critical Reviews in Biomedical Engineering

Volumn 39, Issue 6, 2011, Pages 535-555

  Candiello, Joseph E ^a   Jaramillo, Maria ^a   Goh, Saik Kia ^a   Banerjee, Ipsita ^a,b  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Biomaterials; Extracellular matrix; Microencapsulation; Natural material; Pancreas; Synthetic material

Indexed keywords

BIOMATERIALS; CELL CULTURE; CELLS; CURING; CYTOLOGY; INSULIN; MICROENCAPSULATION;

CHEMICAL PERTURBATIONS; EXTRACELLULAR MATRICES; ISLET TRANSPLANTATION; ISLETS OF LANGERHANS; NATURAL MATERIALS; PANCREAS; STEM CELL DIFFERENTIATION; SYNTHETIC MATERIALS;

STEM CELLS;

ANTIDIABETIC AGENT; BIOMATERIAL; INSULIN;

CELL DIFFERENTIATION; CELL ENCAPSULATION; GRAFT REJECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MATERIALS TESTING; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 84555208589     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v39.i6.40     Document Type: Review

References (134)

1. MacFarlane WM, Bone AJ, Harrison M. Pancreas biology, pathology, and tissue engineering. In: Santin M, editor. Strategies in regenerative medicine. New York: Springer Science; 2009. p. 261-78.
2. Kim SK, Hebrok M, Melton DA. Notochord to endoderm signaling is required for pancreas development. Development. 1997 Nov;124(21):4243-52.
3. Hebrok M, Kim SK, Melton DA. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 1998 Jun 1;12(11):1705-13.
4. Hebrok M, Kim SK, St Jacques B, McMahon AP, Melton DA. Regulation of pancreas development by hedgehog signaling. Development. 2000 Nov;127(22):4905-13.
5. Kumar M, Jordan N, Melton D, Grapin-Botton A. Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev Biol. 2003 Jul 1;259(1):109-22.
6. Jorgensen MC, Ahnfelt-Ronne J, Hald J, Madsen OD, Serup P, Hecksher-Sorensen J. An illustrated review of early pancreas development in the mouse. Endocr Rev. 2007 Oct;28(6):685-705.
7. Hisaoka M, Haratake J, Hashimoto H. Pancreatic morphogenesis and extracellular matrix organization during rat development. Differentiation. 1993;53(3):163-72.
8. Jiang FX, Harrison LC. Extracellular signals and pancreatic beta-cell development: a brief review. Mol Med. 2002 Dec;8(12):763-70.
9. Meyer T, Chodnewska I, Czub S, Hamelmann W, Beutner U, Otto C, Thiede A, Ulrichs K. Extracellular matrix proteins in the porcine pancreas: a structural analysis for directed pancreatic islet isolation. Transplant Proc. 1998 Mar;30(2):354.
10. Van Deijnen JH, Van Suylichem PT, Wolters GH, Van Schilfgaarde R. Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res. 1994 Jul;277(1):115-21.
11. Bulow HE, Hobert O. The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol. 2006;22:375-407.
12. Jiang FX, Cram DS, DeAizpurua HJ, Harrison LC. Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes. 1999 Apr;48(4):722-30.
13. Falk M, Ferletta M, Forsberg E, Ekblom P. Restricted distribution of laminin alpha1 chain in normal adult mouse tissues. Matrix Biol. 1999 Dec;18(6):557-68.
14. Virtanen I, Gullberg D, Rissanen J, Kivilaakso E, Kiviluoto T, Laitinen LA, Lehto VP, Ekblom P. Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp Cell Res. 2000 Jun 15;257(2):298-309.
15. Crisera CA, Kadison AS, Breslow GD, Maldonado TS, Longaker MT, Gittes GK. Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes. 2000 June 1, 2000;49(6):936-44.
16. Gittes GK, Galante PE, Hanahan D, Rutter WJ, Debase HT. Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors. Development. 1996 February 1, 1996;122(2):439-47.
17. Li Z, Manna P, Kobayashi H, Spilde T, Bhatia A, Preuett B, Prasadan K, Hembree M, Gittes GK. Multifaceted pancreatic mesenchymal control of epithelial lineage selection. Devel Biol. 2004;269(1):252-63.
18. Jiang FX, Georges-Labouesse E, Harrison LC. Regulation of laminin-1-induced pancreatic β-cell differentiation by α6 integrin and α-dystroglycan. Mol Med. 2001;7(2):107-14.
19. De Breuck S, Lardon J, Rooman I, Bouwens L. Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells. Diabetologia. 2003 Jul;46(7):926-33.
20. Fitzgerald DP, Seaman C, Cooper HM. Localization of Neogenin protein during morphogenesis in the mouse embryo. Dev Dyn. 2006 Jun;235(6):1720-5.
21. Yebra M, Montgomery AMP, Diaferia GR, Kaido T, Silletti S, Perez B, Just ML, Hildbrand S, Hurford R, Florkiewicz E, Tessier-Lavigne M, Cirulli V. Recognition of the neural chemoattractant netrin-1 by integrins α6β4 and α3β1 regulates epithelial cell adhesion and migration. Dev Cell. 2003;5(5):695-707.
22. Cirulli V, Beattie GM, Klier G, Ellisman M, Ricordi C, Quaranta V, Frasier F, Ishii JK, Hayek A, Salomon DR. Expression and function of αvβ3 and αvβ5 integrins in the developing pancreas. J Cell Biol. 2000 Sept 18;150(6):1445-60.
23. Kaido T, Yebra M, Cirulli V, Montgomery AM. Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. J Biol Chem. 2004 Dec 17;279(51):53762-9.
24. Otonkoski T, Banerjee M, Korsgren O, Thornell LE, Virtanen I. Unique basement membrane structure of human pancreatic islets: implications for β-cell growth and differentiation. Diabetes Obesity Metab. 2008;10:119-27.
25. Meyer T, Czub S, Chodnewska I, Beutner U, Hamelmann W, Klock G, Zimmermann U, Thiede A, Ulrichs K. Expression pattern of extracellular matrix proteins in the pancreas of various domestic pig breeds, the Goettingen minipig and the wild boar. Ann Transplant. 1997;2(3):17-26.
26. Jiang FX, Naselli G, Harrison LC. Distinct distribution of laminin and its integrin receptors in the pancreas. J Histochem Cytochem. 2002 Dec;50(12):1625-32.
27. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, Fassler R, Gu G, Gerber HP, Ferrara N, Melton DA, Lammert E. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell. 2006 Mar;10(3):397-405.
28. van Deijnen JH, Hulstaert CE, Wolters GH, van Schilfgaarde R. Significance of the peri-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig, and man. Cell Tissue Res. 1992 Jan;267(1):139-46.
29. Virtanen I, Banerjee M, Palgi J, Korsgren O, Lukinius A, Thornell LE, Kikkawa Y, Sekiguchi K, Hukkanen M, Konttinen YT, Otonkoski T. Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia. 2008 Jul;51(7):1181-91.
30. Armanet M, Wojtusciszyn A, Morel P, Parnaud G, Rousselle P, Sinigaglia C, Berney T, Bosco D. Regulated laminin-332 expression in human islets of Langerhans. FASEB J. 2009 Dec;23(12):4046-55.
31. Parnaud G, Hammar E, Rouiller DG, Armanet M, Halban PA, Bosco D. Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix. Diabetes. 2006 May;55(5):1413-20.
32. Hughes SJ, Clark A, McShane P, Contractor HH, Gray DW, Johnson PR. Characterisation of collagen VI within the islet-exocrine interface of the human pancreas: implications for clinical islet isolation? Transplantation. 2006 Feb 15;81(3):423-6.
33. Pancreatitis. National Digestive Diseases Information Clearinghouse: US Department of Health and Human Services. NIH Publication No. 08-1596; July 2008.
34. Ansari D, Rosendahl A, Elebro J, Andersson R. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg. 2011 Aug;98(8):1041-55.
35. Castellanos E, Berlin J, Cardin DB. Current treatment options for pancreatic carcinoma. Curr Oncol Rep. Jun;13(3):195-205.
36. Liao YH, Verchere CB, Warnock GL. Adult stem or progenitor cells in treatment for type 1 diabetes: current progress. Can J Surg. 2007 Apr;50(2):137-42.
37. Srinivasan P, Huang GC, Amiel SA, Heaton ND. Islet cell transplantation. Postgrad Med J. 2007 Apr;83(978):224-9.
38. Lee MS, Gu D, Feng L, Curriden S, Arnush M, Krahl T, Gurushanthaiah D, Wilson C, Loskutoff DL, Fox H, Sarvetnick N. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am J Pathol. 1995 Jul;147(1):42-52.
39. Sanvito F, Nichols A, Herrera PL, Huarte J, Wohlwend A, Vassalli JD, Orci L. TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes. Biochem Biophys Res Commun. 1995 Dec 26;217(3):1279-86.
40. Kennedy RH, Bockman DE, Uscanga L, Choux R, Grimaud JA, Sarles H. Pancreatic extracellular matrix alterations in chronic pancreatitis. Pancreas. 1987;2(1):61-72.
41. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999 Apr;44(4):534-41.
42. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998 Aug;115(2):421-32.
43. Kihara Y, Tashiro M, Nakamura H, Yamaguchi T, Yoshikawa H, Otsuki M. Role of TGF-β1, extracellular matrix, and matrix metalloproteinase in the healing process of the pancreas after induction of acute necrotizing pancreatitis using arginine in rats. Pancreas. 2001;23(3):288-95.
44. Elsasser HP, Adler G, Kern HF. Fibroblast structure and function during regeneration from hormone-induced acute pancreatitis in the rat. Pancreas. 1989;4(2):169-78.
45. Elsasser HP, Haake T, Grimmig M, Adler G, Kern HF. Repetitive cerulein-induced pancreatitis and pancreatic fibrosis in the rat. Pancreas. 1992;7(3):385-90.
46. Gress T, Muller-Pillasch F, Elsasser HP, Bachem M, Ferrara C, Weidenbach H, Lerch M, Adler G. Enhancement of transforming growth factor beta 1 expression in the rat pancreas during regeneration from caerulein-induced pancreatitis. Eur J Clin Invest. 1994 Oct;24(10):679-85.
47. Gress TM, Muller-Pillasch F, Lerch MM, Friess H, Buchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer. 1995 Aug 9;62(4):407-13.
48. Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maillet B, Kloppel G. Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer. 1994 Jan;69(1):144-51.
49. Gress TM, Menke A, Bachem M, Müller-Pillasch F, Ellenrieder V, Weidenbach H, Wagner M, Adler G. Role of extracellular matrix in pancreatic diseases. Digestion. 1998;59(6):625-37.
50. Vaquero EC, Edderkaoui M, Nam KJ, Gukovsky I, Pandol SJ, Gukovskaya AS. Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. Gastroenterology. 2003 Oct;125(4):1188-202.
51. Han J, McLane B, Kim EH, Yoon JW, Jun HS. Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter. Mol Ther. Mar;19(3):470-8.
52. Welsh N. Prospects for gene therapy of diabetes mellitus. Gene Ther. 2000 Feb;7(3):181-2.
53. Shapiro A, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G, Kneteman N, Rajotte R. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Eng J Med. 2000;343(4):230-8.
54. Langer RM. Islet transplantation: lessons learned since the Edmonton breakthrough. Transplant Proc. Jun;42(5):1421-4.
55. Wang RN, Rosenberg L. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol. 1999 Nov;163(2):181-90.
56. Stendahl JC, Kaufman DB, Stupp SI. Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant. 2009;18(1):1-12.
57. Lucas-Clerc C, Massart C, Campion JP, Launois B, Nicol M. Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol. 1993 Jul;94(1):9-20.
58. Daoud JT, Petropavlovskaia MS, Patapas JM, Degrandpre CE, Diraddo RW, Rosenberg L, Tabrizian M. Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials. Feb;32(6):1536-42.
59. Weber LM, Anseth KS. Hydrogel encapsulation environments functionalized with extracellular matrix interactions increase islet insulin secretion. Matrix Biol. 2008 Oct;27(8):667-73.
60. Zhao Y, Xu J, Wei J, Li J, Cai J, Miao G. Preservation of islet survival by upregulating alpha3 integrin signaling: the importance of 3-dimensional islet culture in basement membrane extract. Transplant Proc. Dec;42(10):4638-42.
61. Chun S, Huang Y, Xie WJ, Hou Y, Huang RP, Song YM, Liu XM, Zheng W, Shi Y, Song CF. Adhesive growth of pancreatic islet cells on a polyglycolic acid fibrous scaffold. Transplant Proc. 2008 Jun;40(5):1658-63.
62. Yuan Y, Cong C, Zhang J, Wei L, Li S, Chen Y, Tan W, Cheng J, Li Y, Zhao X, Lu Y. Self-assembling peptide nanofiber as potential substrates in islet transplantation. Transplant Proc. 2008 Oct;40(8):2571-4.
63. Zhao M, Song C, Zhang W, Hou Y, Huang R, Song Y, Xie W, Shi Y. The three-dimensional nanofiber scaffold culture condition improves viability and function of islets. J Biomed Mater Res A. Sep 1;94(3):667-72.
64. Lock LT, Tzanakakis ES. Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng. 2007 Jul;13(7):1399-412.
65. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677-89.
66. Lyssiotis CA, Lairson LL, Boitano AE, Wurdak H, Zhu S, Schultz PG. Chemical control of stem cell fate and developmental potential. Angewandte Chemie International Edition. 2011;50(1):200-42.
67. Firestone AJ, Chen JK. Controlling destiny through chemistry: small-molecule regulators of cell fate. ACS Chem Biol. 2009;5(1):15-34.
68. Li W, Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci. 2010;31(1):36-45.
69. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman MA, Kroon E, Carpenter MK, Baetge EE. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotech. 2006;24(11):1392-401.
70. Phillips BW, Hentze H, Rust WL, Chen QP, Chipperfield H, Tan EK, Abraham S, Sadasivam A, Soong PL, Wang ST, Lim R, Sun W, Colman A, Dunn NR. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev. 2007 Aug;16(4):561-78.
71. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 2009 Apr;19(4):429-38.
72. Jiang W, Shi Y, Zhao D, Chen S, Yong J, Zhang J, Qing T, Sun X, Zhang P, Ding M, Li D, Deng H. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007 Apr;17(4):333-44.
73. Basma H, Soto-Gutierrez A, Yannam GR, Liu L, Ito R, Yamamoto T, Ellis E, Carson SD, Sato S, Chen Y, Muirhead D, Navarro-Alvarez N, Wong RJ, Roy-Chowdhury J, Platt JL, Mercer DF, Miller JD, Strom SC, Kobayashi N, Fox IJ. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology. 2009 Mar;136(3):990-9.
74. Jiang J, Au M, Lu K, Eshpeter A, Korbutt G, Fisk G, Majumdar AS. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells. 2007 Aug;25(8):1940-53.
75. Ross RS. Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors. Cardiovas Res. 2004 August 15, 2004;63(3):381-90.
76. Kruegel J, Miosge N. Basement membrane components are key players in specialized extracellular matrices. Cell Mol Life Sci. 2010;67(17):2879-95.
77. McMillan JR, Akiyama M, Shimizu H. Epidermal basement membrane zone components: ultrastructural distribution and molecular interactions. J Dermatol Sci. 2003;31(3):169-77.
78. Öberg-Welsh C. Long-term culture in Matrigel enhances the insulin secretion of fetal porcine islet-like cell clusters in vitro. Pancreas. 2001;22(2):157-63.
79. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res. 1992;202(1):1-8.
80. Feng G, De-quan W, Yan-hua H, Guang-xin J. Extracellular matrix gel is necessary for in vitro cultivation of insulin producing cells from human umbilical cord blood derived mesenchymal stem cells. Chinese Med J. 2008;121 811-8(9):8.
81. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song K-H, Sharma A, O'Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci. 2000 July 5, 2000;97(14):7999-8004.
82. Boretti MI, Gooch KJ. Effect of extracellular matrix and 3D morphogenesis on islet hormone gene expression by Ngn3-infected mouse pancreatic ductal epithelial cells. Tissue Eng A. 2008;14(12):1927-37.
83. Gittes G, Galante P, Hanahan D, Rutter W, Debase H. Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors. Development. 1996;122(2):439-47.
84. Banerjee I, Sharma N, Yarmush M. Impact of co-culture on pancreatic differentiation of embryonic stem cells. J Tissue Eng Regen Med. 2011;5(4):313-23.
85. Hamamoto K, Yamada S, Hara A, Kodera T, Seno M, Kojima I. Extracellular matrix modulates insulin production during differentiation of AR42J cells: functional role of Pax6 transcription factor. J Cell Biochem. 2011;112(1):318-29.
86. Kaido TJ, Yebra M, Kaneto H, Cirulli V, Hayek A, Montgomery AMP. Impact of integrin-matrix interaction and signaling on insulin gene expression and the mesenchymal transition of human β-cells. J Cell Physiol. 2010;224(1):101-11.
87. Jiang FX, Cram DS, DeAizpurua HJ, Harrison LC. Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes. 1999 April 1, 1999;48(4):722-30.
88. Jiang F-X, Harrison LC. Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation. Differentiation. 2005;73(1):45-9.
89. Jiang F-X, Harrison LC. Convergence of bone morphogenetic protein and laminin-1 signaling pathways promotes proliferation and colony formation by fetal mouse pancreatic cells. Exp Cell Res. 2005;308(1):114-22.
90. Higuchi Y, Shiraki N, Yamane K, Qin Z, Mochitate K, Araki K, Senokuchi T, Yamagata K, Hara M, Kume K, Kume S. Synthesized basement membranes direct the differentiation of mouse embryonic stem cells into pancreatic lineages. J Cell Sci. 2010 August 15, 2010;123(16):2733-42.
91. Leite A, Corrêa-Giannella M, Dagli M, Fortes M, Vegas V, Giannella-Neto D. Fibronectin and laminin induce expression of islet cell markers in hepatic oval cells in culture. Cell Tissue Res. 2007;327(3):529-37.
92. Lin H-Y, Tsai C-C, Chen L-L, Chiou S-H, Wang Y-J, Hung S-C. Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK. J Biomed Sci. 2010;17(1):56.
93. Darribère T, Schwarzbauer JE. Fibronectin matrix composition and organization can regulate cell migration during amphibian development. Mech Dev. 2000;92(2):239-50.
94. Chang C-F, Hsu K-H, Chiou S-H, Ho LL-T, Fu Y-S, Hung S-C. Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells. J Biomed Mat Res A. 2008;86A(4):1097-105.
95. Clark C, Na K. Letter: Type IV collagen: a universal component of basement membranes? Dev Biol 1974;40(1):1-6.
96. Mason MN, Arnold CA, Mahoney MJ. Entrapped collagen type 1 promotes differentiation of embryonic pancreatic precursor cells into glucose-responsive β-cells when cultured in three-dimensional PEG hydrogels. Tissue Eng A. 2009;15(12):3799-808.
97. Nagaya M, Katsuta H, Kaneto H, Bonner-Weir S, Weir GC. Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells. J Endocrinol. 2009 April 1, 2009;201(1):37-47.
98. Wang X, Ye K. Three-dimensional differentiation of embryonic stem cells into islet-like insulin-producing clusters. Tissue Eng A. 2009 2009/08/01;15(8):1941-52.
99. Kulseng B, Espevik T, Skjåk-Braek G. Treatment of diabetes mellitus with transplantation of immunoprotected pancreatic islet tissue. Tidsskr Nor Laegeforen 1999 119(28):4219-23.
100. Maguire T, Davidovich AE, Wallenstein EJ, Novik E, Sharma N, Pedersen H, Androulakis IP, Schloss R, Yarmush M. Control of hepatic differentiation via cellular aggregation in an alginate microenvironment. Biotechnol Bioeng. 2007;98(3):631-44.
101. Chayosumrit M, Tuch B, Sidhu K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials. 2010 Jan;31(3):505-14.
102. Wang N, Adams G, Buttery L, Falcone FH, Stolnik S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotechnol. 2009 Dec;144(4):304-12.
103. Racanicchi L, Conti V, Basta G, Montanucci P, Calafiore R. Effects of poly-L-lysine and collagen on FH-B-TPN cell differentiation into endocrine cell phenotype. Transplant Proc. 2008;40(2):419-21.
104. Fujita-Yamaguchi Y, Sacks DB, McDonald JM, Sahal D, Kathuria S. Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine). Biochem J. 1989 Nov 1;263(3):10.
105. Mason MN, Mahoney MJ. Selective β-cell differentiation of dissociated embryonic pancreatic precursor cells cultured in synthetic polyethylene glycol hydrogels. Tissue Engineering Part A. 2009;15(6):1343-52.
106. Mason MN, Mahoney MJ. Inhibition of gamma-secretase activity promotes differentiation of embryonic pancreatic precursor cells into functional islet-like clusters in poly(ethylene glycol) hydrogel culture. Tissue Engineering Part A. 2010;16(8):2593-603.
107. de Groot M, Schuurs TA, van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res. 2004 Sep;121(1):141-50.
108. Lanza RP, Chick WL. Transplantation of pancreatic islets. Ann N Y Acad Sci. 1997 Dec 31;831:323-31.
109. Maki T, Ubhi CS, Sanchez-Farpon H, Sullivan SJ, Borland K, Muller TE, Solomon BA, Chick WL, Monaco AP. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation. 1991 Jan;51(1):43-51.
110. Monaco AP, Maki T, Ozato H, Carretta M, Sullivan SJ, Borland KM, Mahoney MD, Chick WL, Muller TE, Wolfrum J, Solomon B. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg. 1991 Sep;214(3):339-60; discussion 61-2.
111. Reach G. Bioartificial pancreas. Present state and future prospects. Biomed Biochim Acta. 1984;43(5):569-76.
112. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science. 1991 Dec 20;254(5039):1782-4.
113. de Vos P, de Haan BJ, de Haan A, van Zanten J, Faas MM. Factors influencing functional survival of microencapsulated islet grafts. Cell Transplant. 2004;13(5):515-24.
114. Teramura Y, Iwata H. Bioartificial pancreas microencapsulation and conformal coating of Islet of Langerhans. Adv Drug Deliv Rev. Jun 15;62(7-8):827-40.
115. Iwata H, Takagi T, Amemiya H, Shimizu H, Yamashita K, Kobayashi K, Akutsu T. Agarose for a bioartificial pancreas. J Biomed Mater Res. 1992 Jul;26(7):967-77.
116. Iwata H, Kobayashi K, Takagi T, Oka T, Yang H, Amemiya H, Tsuji T, Ito F. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J Biomed Mater Res. 1994 Sep;28(9):1003-11.
117. Iwata H, Takagi T, Kobayashi K, Oka T, Tsuji T, Ito F. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J Biomed Mater Res. 1994 Oct;28(10):1201-7.
118. Kin T, Iwata H, Aomatsu Y, Ohyama T, Kanehiro H, Hisanaga M, Nakajima Y. Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic acid mixed gel. Pancreas. 2002 Jul;25(1):94-100.
119. Luan NM, Teramura Y, Iwata H. Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation. Biomaterials. Dec;31(34):8847-53.
120. Cruise GM, Hegre OD, Lamberti FV, Hager SR, Hill R, Scharp DS, Hubbell JA. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999 May-Jun;8(3):293-306.
121. Hou Y, Song C, Xie WJ, Wei Z, Huang RP, Liu W, Zhang ZL, Shi YB. Excellent effect of three-dimensional culture condition on pancreatic islets. Diabetes Res Clin Pract. 2009 Oct;86(1):11-5.
122. Lim JY, Min BH, Kim BG, Han HJ, Kim SJ, Kim CW, Han SS, Shin JS. A fibrin gel carrier system for islet transplantation into kidney subcapsule. Acta Diabetol. 2009 Sep;46(3):243-8.
123. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980 Nov 21;210(4472):908-10.
124. Halle JP, Bourassa S, Leblond FA, Chevalier S, Beaudry M, Chapdelaine A, Cousineau S, Saintonge J, Yale JF. Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-L-lysine membranes. Transplantation. 1993 Feb;55(2):350-4.
125. Wolters GH, Fritschy WM, Gerrits D, van Schilfgaarde R. A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. J Appl Biomater. 1991 Winter;3(4):281-6.
126. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 1996 Sep 15;98(6):1417-22.
127. King G, Dauglis A, Faulkner P, Goosen M. Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotech Prog. 1987;3:231-40.
128. O'Shea GM, Goosen MF, Sun AM. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta. 1984 May 22;804(1):133-6.
129. Grohn P, Klock G, Schmitt J, Zimmermann U, Horcher A, Bretzel RG, Hering BJ, Brandhorst D, Brandhorst H, Zekorn T, et al. Large-scale production of Ba(2+)-alginate-coated islets of Langerhans for immunoisolation. Exp Clin Endocrinol. 1994;102(5):380-7.
130. Johnson AS, O'Sullivan E, D'Aoust LN, Omer A, Bonner-Weir S, Fisher RJ, Weir GC, Colton CK. Quantitative assessment of islets of langerhans encapsulated in alginate. Tissue Eng Part C Methods. 2011 Apr;17(4):435-49.
131. Hunter SK, Wang Y, Weiner CP, Niebyl J. Encapsulated beta-islet cells as a bioartificial pancreas to treat insulin-dependent diabetes during pregnancy. Am J Obstet Gynecol. 1997 Oct;177(4):746-52.
132. Schneider S, Feilen PJ, Slotty V, Kampfner D, Preuss S, Berger S, Beyer J, Pommersheim R. Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials. 2001 Jul;22(14):1961-70.
133. Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation. 2006 May 15;81(9):1345-53.
134. Prevost P, Flori S, Collier C, Muscat E, Rolland E. Application of AN69 hydrogel to islet encapsulation. Evaluation in streptozotocin-induced diabetic rat model. Ann N Y Acad Sci. 1997 Dec 31;831:344-9.